Resveratrol in human cancer chemoprevention--choosing the 'right' dose.
about
Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progressResveratrol and clinical trials: the crossroad from in vitro studies to human evidenceRegulatory effects of resveratrol on antioxidant enzymes: a mechanism of growth inhibition and apoptosis induction in cancer cellsDietary phytochemicals and cancer chemoprevention: a review of the clinical evidencePromiscuous Effects of Some Phenolic Natural Products on Inflammation at Least in Part Arise from Their Ability to Modulate the Expression of Global Regulators, Namely microRNAsA synergetic screening approach with companion effector for combination therapy: application to retinoblastomaResveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent mannerRapid and simultaneous in situ assessment of aflatoxins and stilbenes using silica plate imprinting mass spectrometry imagingResveratrol, from experimental data to nutritional evidence: the emergence of a new food ingredient.Novel Lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer model.Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage.Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells.Effects of resveratrol supplementation on bone growth in young rats and microarchitecture and remodeling in ageing rats.Human Serum Albumin Increases the Stability of Green Tea Catechins in Aqueous Physiological Conditions.Long Term Exposure to Polyphenols of Artichoke (Cynara scolymus L.) Exerts Induction of Senescence Driven Growth Arrest in the MDA-MB231 Human Breast Cancer Cell Line.Resveratrol: French paradox revisited.Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt/PKB signaling pathway.Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet.Resveratrol analogue 3,4,4'-trihydroxy-trans-stilbene induces apoptosis and autophagy in human non-small-cell lung cancer cells in vitro.Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and miceTargeting sirtuin-1 in Huntington's disease: rationale and current status.Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugsHydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis.Protective effect of resveratrol on arsenic trioxide-induced nephrotoxicity in rats.Resveratrol in the management of human cancer: how strong is the clinical evidence?Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application.mTOR: more targets of resveratrol?Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice.3,4',5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potency.Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells.Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma.Cancer chemopreventive effects of the flavonoid-rich fraction isolated from papaya seeds.A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia.Inhibitory effects of epigenetic modulators and differentiation inducers on human medulloblastoma cell lines.Multiple phytoestrogens inhibit cell growth and confer cytoprotection by inducing manganese superoxide dismutase expression.Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.Autophagy is involved in the effects of resveratrol on prevention of splenocyte apoptosis caused by oxidative stress in restrained mice.Resveratrol inhibits the intracellular calcium increase and angiotensin/endothelin system activation induced by soluble uric acid in mesangial cells.Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.Mechanisms of action of nonpeptide hormones on resveratrol-induced antiproliferation of cancer cells.
P2860
Q21284734-25961634-4BF3-4D25-B2DC-3A5A05CB59DFQ24618313-9EFD201B-52FD-4D09-95C9-0B4F3E2EE7E0Q24619157-65614396-B0E6-44EF-AFCD-DE5711ED08E8Q26745552-E9C98E45-5D62-47B1-B2A2-4479D847914EQ28066929-ECA8D61F-D049-40E8-95D1-348CB41F9E85Q28488349-AEC1D1A9-BD76-4B99-9124-089082EA90C1Q28535352-57F82422-EDAC-4577-8328-9AF47D340EA8Q28540399-17775E47-8DAA-4EC2-9FB4-F17D5D21A9A0Q30655313-825CF9B2-6377-4A0F-AB89-9D69C3B1147EQ31156045-33099400-F984-4C89-A3D2-4B569C098317Q34638026-35BEBF57-4BB7-4635-B71F-E42929B19A82Q34656775-E8B6F6BD-68FD-49ED-AE29-0A8BFAC86E33Q34775081-37D5BDBB-41DF-49FD-BB6B-10A3A38EF1D6Q35731357-5D377C77-FF32-4082-ABA6-BC2EC02CCDC8Q35769198-6298D12C-793A-4A17-97D0-362E22189CF5Q36099455-8A2CECC8-E4AD-40C1-AFF7-B83BBC842070Q36113996-B00329C2-B297-46A0-8A9B-0C2291331DBDQ36586516-293D2B57-DCFC-461C-88C6-F031841A3DEAQ36746148-5AB82FA4-22DB-4F3F-98BC-33DC252FB6CAQ36786996-FB726963-2D73-48C4-B4CF-F2674A0317BEQ36863901-49ECCD1C-1B23-47E2-880E-A7702315446EQ37018003-5690341D-EC53-4BE7-91FB-AEB1C8268C0BQ37026582-56891908-A8DB-495B-B8ED-DE55BDE08E69Q37705672-1DD39D8E-24D6-4637-B2E2-BA2C6DF20A19Q38121595-ECFEDD50-DED3-4FC6-AA3E-C75EA319CD1EQ38139567-F8E4A218-81EC-4393-9077-1F0BC5C4A61BQ38141246-F53D6187-8CDB-41B6-A1B6-A088BA78FD13Q38322940-1BD23717-F70D-4E67-8BF7-45DC885EAB19Q38365582-407E69FD-1034-4BEE-8877-1BC5764B86FBQ38937205-53B92F01-870B-468C-AE48-A3908A8E609CQ38966954-ADEFFF0D-74E6-49AC-A9BB-9725814CA4ABQ38995716-18C6028E-927A-4B00-A668-C872651A8919Q39106004-046EF6BC-8DA2-46C6-8654-E55DB8B82255Q39152245-0DA47BAB-553E-49A7-924D-EE68B88B46E4Q39176151-C22CE8EF-2681-490D-AFEA-DEB29C438231Q39464111-B14EDE3B-62DF-4415-B1CD-9FF3C5A4DEE4Q41926428-262054A8-B5F4-44E2-BC40-3EFFEA624296Q42102624-4DACBD92-4370-483D-8C5D-24966D370310Q43611763-5F09223B-2ED2-48E6-B944-30E93FB715EFQ47862403-B70CB66D-E1B0-4971-A608-8E889DFBDDE0
P2860
Resveratrol in human cancer chemoprevention--choosing the 'right' dose.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Resveratrol in human cancer chemoprevention--choosing the 'right' dose.
@en
Resveratrol in human cancer chemoprevention--choosing the 'right' dose.
@nl
type
label
Resveratrol in human cancer chemoprevention--choosing the 'right' dose.
@en
Resveratrol in human cancer chemoprevention--choosing the 'right' dose.
@nl
prefLabel
Resveratrol in human cancer chemoprevention--choosing the 'right' dose.
@en
Resveratrol in human cancer chemoprevention--choosing the 'right' dose.
@nl
P2093
P2860
P356
P1476
Resveratrol in human cancer chemoprevention--choosing the 'right' dose
@en
P2093
Andreas J Gescher
Edwina Scott
William P Steward
P2860
P356
10.1002/MNFR.201100400
P50
P577
2011-10-07T00:00:00Z